Cargando…
Fermented ginseng, GBCK25, ameliorates steatosis and inflammation in nonalcoholic steatohepatitis model
BACKGROUND: Nonalcoholic steatohepatitis (NASH) is one of the chronic inflammatory liver diseases and a leading cause of advanced liver fibrosis, cirrhosis, and hepatocellular carcinoma. The main purpose of this study was to clarify the effects of GBCK25 fermented by Saccharomyces servazzii GB-07 an...
Autores principales: | Choi, Naeun, Kim, Jong Won, Jeong, Hyeneui, Shin, Dong Gue, Seo, Jeong Hun, Kim, Jong Hoon, Lim, Chae Woong, Han, Kang Min, Kim, Bumseok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437395/ https://www.ncbi.nlm.nih.gov/pubmed/30962734 http://dx.doi.org/10.1016/j.jgr.2017.10.002 |
Ejemplares similares
-
GBCK25, fermented ginseng, attenuates cardiac dysfunction in high fat diet-induced obese mice
por: Sharmila, Judith, et al.
Publicado: (2018) -
A 12-week, randomized, double-blind study to evaluate the efficacy and safety of liver function after using fermented ginseng powder (GBCK25)
por: Jung, Su-Jin, et al.
Publicado: (2020) -
Oral administration of Jinan Red Ginseng and licorice extract mixtures ameliorates nonalcoholic steatohepatitis by modulating lipogenesis
por: Yang, Daram, et al.
Publicado: (2022) -
Γ-Aminobutyric acid promotes methionine-choline deficient diet-induced nonalcoholic steatohepatitis
por: Seok Roh, Yoon, et al.
Publicado: (2017) -
Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis
por: Ganbold, Munkhzul, et al.
Publicado: (2019)